טוען...
Identification of microRNAs that promote erlotinib resistance in non-small cell lung cancer
Lung cancer is the leading cause of cancer-related deaths, demanding improvement in current treatment modalities to reduce the mortality rates. Lung cancer is divided into two major classes with non-small cell lung cancer representing ~84% of lung cancer cases. One strategy widely used to treat non-...
שמור ב:
| הוצא לאור ב: | Biochem Pharmacol |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2020
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7854807/ https://ncbi.nlm.nih.gov/pubmed/32681833 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bcp.2020.114154 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|